Sharma, Som D <br/><br/>
Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.  [electronic resource] 

 -  Molecular cancer therapeutics  Mar 2010 
 - 569-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-09-0638  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Cell Proliferation--drug effects<br/>Cyclooxygenase 2--genetics<br/>Dinoprostone--genetics<br/>Down-Regulation--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Lung Neoplasms--genetics<br/>Mice<br/>Mice, Nude<br/>Proanthocyanidins--pharmacology<br/>Receptors, Prostaglandin E--genetics<br/>Receptors, Prostaglandin E, EP2 Subtype<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays